We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Making Heart-Valve Repair Easier

By HospiMedica staff writers
Posted on 14 Feb 2006
New annuloplasty products are designed to be easier to implant and offer choices that accommodate various approaches to valve repair.

The ATS Simulus annuloplasty products, manufactured by ATS Medical (Minneapolis, MN, USA), are available either in a flexible ring (the ATS Simulus FLX-O Ring) or a flexible band (the ATS Simulus FLX-C Band). More...
They can be used in both the mitral and tricuspid valves, and are designed to maintain the normal physiologic function of the heart valve. The products have been approved by the U.S. Food and Drug Administration (FDA).

Annuloplasty rings and bands are used in those cases where repair of a patient's heart valve is preferable to the complete replacement of the valve. The supporting structure of the valve, called the annulus, is often dilated due to severe mitral regurgitation and is therefore tightened with an annuloplasty ring. These rings are made of flexible polymers and are sutured to the existing annulus to support the repaired valve.

Genesee BioMedical (Denver, CO, USA), a manufacturer of cardiac surgery instruments and devices, was chosen as the exclusive partner of ATS Medical for the development and manufacture of the new line of annuloplasty products.

"The ATS Simulus annuloplasty product line is yet another vital step in our mission to establish ATS Medical as a leader in cardiac surgery,” said Michael D. Dale, chairman, president, and CEO of ATS. "The dedicated and talented staff of Genesee BioMedical has provided us with the ability to accelerate our entry into the important and growing heart-valve repair market segment.”



Related Links:
ATS Medical
Genesee BioMedical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.